Anantha Rajmohan Muthusamy

This inventor holds 22 USPTO granted patents and 16 published patent applications and 10 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Assia Chemical Industries Ltd., Watson Laboratories Inc., Teva Pharmaceuticals International Gmbh. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anantha Rajmohan Muthusamy. Retrieved from https://idiyas.com/inventor/anantha-rajmohan-muthusamy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 16)

% Patents Active = 90.9

EPO Patents = 10 (Patent Applications = 34)

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Delhi, IN (2021)
Sivakasi, IN (2021 - 2024)

Company Filing History:

16 out of 42

Assia Chemical Industries Ltd.

patents

3 out of 39

Watson Laboratories Inc.

patents

2 out of 54

Teva Pharmaceuticals International Gmbh

patents

4. 1 out of 5

Tapi Czech Industries S.r.o.

patents

Years Active: 2021-2026

Loading Chart...

Areas of Expertise:

Polymorphs

Solid State Forms

Vericiguat

Tideglusib

Nirogacestat

Ponesimod

Danicopan

Ensifentrine

Glasdegib

Remimazolam

Ivosidenib

Selinexor

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760020 - Solid state forms of vericiguat and process for preparation thereof (2026-10-13),

2. 12740969 - Solid state forms of Tideglusib and process for preparation thereof (2026-09-22),

3. 12735401 - Solid state forms of Danicopan and process thereof (2026-09-15),

4. 12735391 - Polymorphs of Ponesimod (2026-09-15),

5. 12734152 - Solid state forms of Nirogacestat salts (2026-09-15),

6. 12698260 - Solid state form of centanafadine HCL and process for preparation thereof (2026-08-04),

7. 12692265 - Solid state forms of Ensifentrine and process for preparation thereof (2026-07-28),

8. 12668581 - Processes for the preparation of Glasdegib and salt thereof and solid state forms of Glasdegib maleate and process for preparation thereof (2026-06-30),

9. 12662486 - Solid state forms of AT-001 and process for preparation thereof (2026-06-23),

10. 12662452 - Solid state forms of lucerastat and process for preparation thereof (2026-06-23),

11. 12234246 - Solid state forms of baloxavir marboxil (2025-02-25),

12. 12091388 - Solid state forms of Reproxalap (2024-09-17),

13. 12043597 - Crystalline polymorphs of Rivoceranib and Rivoceranib mesylate (2024-07-23),

14. 11820776 - Process for the preparation of Remimazolam and solid state forms of Remimazolam salts (2023-11-21),

15. 11673880 - Solid state forms of ivosidenib (2023-06-13),

Title: The Innovative Journey of Anantha Rajmohan Muthusamy

Introduction: Anantha Rajmohan Muthusamy, a talented inventor hailing from Sivakasi, India, has made significant contributions to the field of innovations with his creative mind and dedication.

Latest Patents: Anantha Rajmohan Muthusamy holds several patents in various technological domains, showcasing his versatility and expertise in inventing cutting-edge solutions to real-world problems.

Career Highlights: Throughout his illustrious career, Anantha Rajmohan Muthusamy has been recognized for his groundbreaking inventions that have revolutionized industries. His commitment to pushing the boundaries of innovation has led to the development of solutions that have positively impacted society.

Collaborations: Anantha Rajmohan Muthusamy has collaborated with leading research institutions, universities, and companies to further his inventions and bring them to market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Anantha Rajmohan Muthusamy's passion for innovation, coupled with his technical expertise, has established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire future generations of innovators.

Profile summary based on public USPTO records.